Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01319_DB08815_nanopub.RAJcZi2tz15nMWIcT4zHjTrHUpfqk-rnjcJI0iJSYz5JI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01319_DB08815 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01319_DB08815 label "DDI between Fosamprenavir and Lurasidone - Concomitant therapy with a strong CYP3A4 inhibitor will increase level or effect of lurasidone. Coadministration with lurasidone is contraindicated. [drugbank_resource:DB01319_DB08815]" assertion.
- drugbank_resource:DB01319_DB08815 identifier "drugbank_resource:DB01319_DB08815" assertion.
- drugbank_resource:DB01319_DB08815 title "DDI between Fosamprenavir and Lurasidone - Concomitant therapy with a strong CYP3A4 inhibitor will increase level or effect of lurasidone. Coadministration with lurasidone is contraindicated." assertion.
- drugbank:DB01319 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01319_DB08815 assertion.
- drugbank:DB08815 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01319_DB08815 assertion.